Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on September 2, 2026

2 hours ago

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026

Indeterminate GlobeNewswire

2 hours ago

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 août 2026

Indeterminate GlobeNewswire

2 hours ago

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

2 hours ago

BioRestorative Therapies Announces Reverse Stock Split

Indeterminate GlobeNewswire

3 hours ago

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Supernus Pharmaceuticals to Participate in September Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Vireo Growth Announces Conference Attendance for September 2026

Indeterminate GlobeNewswire

4 hours ago

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean

Indeterminate GlobeNewswire

4 hours ago

SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

Indeterminate GlobeNewswire

4 hours ago

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

Indeterminate GlobeNewswire

4 hours ago

Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients

Indeterminate GlobeNewswire

4 hours ago

Nyxoah Annonce que l'Étude Pivot Américaine ACCCESS Atteint ses Critères Principaux de Sécurité et d'Efficacité chez les Patients Présentant un Collapsus Concentrique Complet

Indeterminate GlobeNewswire

4 hours ago

Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

Indeterminate GlobeNewswire

4 hours ago

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

Indeterminate GlobeNewswire

4 hours ago

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

4 hours ago

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Option Care Health to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire